UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation

Biochemical and biophysical research communications, 2013-11, Vol.441 (4), p.862-866

2013

Volltextzugriff (PDF)

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis

JAMA neurology, 2015-01, Vol.72 (1), p.58

2015

Volltextzugriff (PDF)

Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers

Neurobiology of aging, 2013-05, Vol.34 (5), p.1462-1468

2013

Volltextzugriff (PDF)

SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy

Human molecular genetics, 2015-12, Vol.24 (24), p.7111-7120

2015

Volltextzugriff (PDF)

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue

PloS one, 2011-07, Vol.6 (7), p.e22489-e22489

2011

Volltextzugriff (PDF)

Inflammatory profile in LRRK2-associated prodromal and clinical PD

Journal of neuroinflammation, 2016-05, Vol.13 (1), p.122-122, Article 122

2016

Volltextzugriff (PDF)

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

Movement disorders, 2016-03, Vol.31 (3), p.335-343

2016

Volltextzugriff (PDF)

Study of High-Flow Argon Through Cascaded Arc for Use as a Gas Target Isolator

IEEE transactions on plasma science, 2019-05, Vol.47 (5), p.2752-2758

2019

Volltextzugriff (PDF)

The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism

Journal of molecular medicine (Berlin, Germany), 2013-12, Vol.91 (12), p.1399-1406

2013

Volltextzugriff (PDF)

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

Parkinsonism & related disorders, 2015-07, Vol.21 (7), p.717-722

2015

Volltextzugriff (PDF)

Experimental Demonstration of the Thin-Film Liquid-Metal Jet as a Charge Stripper

Physical review letters, 2022-05, Vol.128 (21), p.212301-212301, Article 212301

2022

Volltextzugriff (PDF)

The long-acting dopamine receptor agonist Cabergoline in early Parkinson's disease: Final results of a 5-year, double-blind, levodopa-controlled study

CNS drugs, 2004-01, Vol.18 (11), p.733-746

2004

Volltextzugriff (PDF)

Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

Neuron (Cambridge, Mass.), 2004-11, Vol.44 (4), p.595-600

2004

Volltextzugriff (PDF)

Plasma Window for containment of high pressure gas for use with a gas Charge Stripper

2018 IEEE International Conference on Plasma Science (ICOPS), 2018, p.1-1

2018

Volltextzugriff (PDF)

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics

Neuroscience letters, 2013-03, Vol.537, p.1-5

2013

Volltextzugriff (PDF)

GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment

Journal of human genetics, 2015-10, Vol.60 (10), p.637-640

2015

Volltextzugriff (PDF)

Neurogenetic Disorders in the Basque Population

Annals of human genetics, 2015-01, Vol.79 (1), p.57-75

2015

Volltextzugriff (PDF)

Analysis of Fine Motor Skills in Essential Tremor: Combining Neuroimaging and Handwriting Biomarkers for Early Management

Frontiers in human neuroscience, 2021-06, Vol.15, p.648573-648573

2021

Volltextzugriff (PDF)

Relationship between the efficacy of rivastigmine and apolipoprotein E (ε4) in patients with mild to moderately severe alzheimer disease

Alzheimer disease and associated disorders, 2006-10, Vol.20 (4), p.248-254

2006

Volltextzugriff (PDF)

Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques

Movement disorders, 2006-11, Vol.21 (11), p.1954-1959

2006

Volltextzugriff (PDF)

Mutations in Progranulin Gene: Clinical, Pathological, and Ribonucleic Acid Expression Findings

Biological psychiatry (1969), 2008-05, Vol.63 (10), p.946-952

2008

Volltextzugriff (PDF)

Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers

Neurology, 2016-03, Vol.86 (11), p.994-999

2016

Volltextzugriff (PDF)

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2

Movement disorders, 2009-10, Vol.24 (13), p.1998-2001

2009

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(352)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis

Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers

SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue

Inflammatory profile in LRRK2-associated prodromal and clinical PD

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

Study of High-Flow Argon Through Cascaded Arc for Use as a Gas Target Isolator

The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

Experimental Demonstration of the Thin-Film Liquid-Metal Jet as a Charge Stripper

The long-acting dopamine receptor agonist Cabergoline in early Parkinson's disease: Final results of a 5-year, double-blind, levodopa-controlled study

Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

Plasma Window for containment of high pressure gas for use with a gas Charge Stripper

Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics

GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment

Neurogenetic Disorders in the Basque Population

Analysis of Fine Motor Skills in Essential Tremor: Combining Neuroimaging and Handwriting Biomarkers for Early Management

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

Relationship between the efficacy of rivastigmine and apolipoprotein E (ε4) in patients with mild to moderately severe alzheimer disease

Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques

Mutations in Progranulin Gene: Clinical, Pathological, and Ribonucleic Acid Expression Findings

Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2

Suchergebnisse filtern